A citation-based method for searching scientific literature

Barry Kennedy, Peter Branagan, Fiachra Moloney, Muhammad Haroon, Oisin J O'Connell, Terence M O'Connor, Kevin O'Regan, Sinead Harney, Michael T Henry. Sarcoidosis Vasc Diffuse Lung Dis 2015
Times Cited: 23







List of co-cited articles
328 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
30

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
30

Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis.
Angelo De Lauretis, Piersante Sestini, Panagiotis Pantelidis, Rachel Hoyles, David M Hansell, Nicole S L Goh, Christopher J Zappala, Dina Visca, Toby M Maher, Christopher P Denton,[...]. J Rheumatol 2013
124
30

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.
Donald P Tashkin, Michael D Roth, Philip J Clements, Daniel E Furst, Dinesh Khanna, Eric C Kleerup, Jonathan Goldin, Edgar Arriola, Elizabeth R Volkmann, Suzanne Kafaja,[...]. Lancet Respir Med 2016
373
30

High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis.
Anna-Maria Hoffmann-Vold, Anders Heiervang Tennøe, Torhild Garen, Øyvind Midtvedt, Aurelija Abraityte, Trond Mogens Aaløkken, May Britt Lund, Cathrine Brunborg, Pål Aukrust, Thor Ueland,[...]. Chest 2016
46
30

Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis.
Lenny van Bon, Alsya J Affandi, Jasper Broen, Romy B Christmann, Renoud J Marijnissen, Lukasz Stawski, Giuseppina A Farina, Giuseppina Stifano, Allison L Mathes, Marta Cossu,[...]. N Engl J Med 2014
226
30

Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease.
Muriel Elhai, Anna Maria Hoffmann-Vold, Jérôme Avouac, Sonia Pezet, Anne Cauvet, Agathe Leblond, Håvard Fretheim, Torhild Garen, Masataka Kuwana, Øyvind Molberg,[...]. Arthritis Rheumatol 2019
41
30

Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.
Oliver Distler, Kristin B Highland, Martina Gahlemann, Arata Azuma, Aryeh Fischer, Maureen D Mayes, Ganesh Raghu, Wiebke Sauter, Mannaig Girard, Margarida Alves,[...]. N Engl J Med 2019
368
30

MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis.
Ivan O Rosas, Thomas J Richards, Kazuhisa Konishi, Yingze Zhang, Kevin Gibson, Anna E Lokshin, Kathleen O Lindell, Jose Cisneros, Sandra D Macdonald, Annie Pardo,[...]. PLoS Med 2008
340
26

Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis.
Thomas J Richards, Naftali Kaminski, Fred Baribaud, Susan Flavin, Carrie Brodmerkel, Daniel Horowitz, Katherine Li, Jiin Choi, Louis J Vuga, Kathleen O Lindell,[...]. Am J Respir Crit Care Med 2012
238
26

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
26

Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis.
Anna L Peljto, Yingze Zhang, Tasha E Fingerlin, Shwu-Fan Ma, Joe G N Garcia, Thomas J Richards, Lori J Silveira, Kathleen O Lindell, Mark P Steele, James E Loyd,[...]. JAMA 2013
267
26

Interstitial lung disease in systemic sclerosis: a simple staging system.
Nicole S L Goh, Sujal R Desai, Srihari Veeraraghavan, David M Hansell, Susan J Copley, Toby M Maher, Tamera J Corte, Clare R Sander, Jonathan Ratoff, Anand Devaraj,[...]. Am J Respir Crit Care Med 2008
570
26

Changes in causes of death in systemic sclerosis, 1972-2002.
Virginia D Steen, Thomas A Medsger. Ann Rheum Dis 2007
915
26

Cyclophosphamide versus placebo in scleroderma lung disease.
Donald P Tashkin, Robert Elashoff, Philip J Clements, Jonathan Goldin, Michael D Roth, Daniel E Furst, Edgar Arriola, Richard Silver, Charlie Strange, Marcy Bolster,[...]. N Engl J Med 2006
908
26

Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis.
Nicole S Goh, Rachel K Hoyles, Christopher P Denton, David M Hansell, Elisabetta A Renzoni, Toby M Maher, Andrew G Nicholson, Athol U Wells. Arthritis Rheumatol 2017
121
26

Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis.
K P Tiev, T Hua-Huy, A Kettaneh, M Gain, S Duong-Quy, C Tolédano, J Cabane, A T Dinh-Xuan. Eur Respir J 2011
66
26


CCL2 in the Circulation Predicts Long-Term Progression of Interstitial Lung Disease in Patients With Early Systemic Sclerosis: Data From Two Independent Cohorts.
Minghua Wu, Murray Baron, Claudia Pedroza, Gloria A Salazar, Jun Ying, Julio Charles, Sandeep K Agarwal, Marie Hudson, Janet Pope, Xiaodong Zhou,[...]. Arthritis Rheumatol 2017
29
26

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Marilyn K Glassberg, David Kardatzke, Talmadge E King, Lisa Lancaster, Steven A Sahn, Javier Szwarcberg,[...]. Lancet 2011
21

An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features.
Aryeh Fischer, Katerina M Antoniou, Kevin K Brown, Jacques Cadranel, Tamera J Corte, Roland M du Bois, Joyce S Lee, Kevin O Leslie, David A Lynch, Eric L Matteson,[...]. Eur Respir J 2015
422
21

Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma.
Faye N Hant, Anna Ludwicka-Bradley, He-Jing Wang, Ning Li, Robert Elashoff, Donald P Tashkin, Richard M Silver. J Rheumatol 2009
96
21

Predictors of mortality and progression in scleroderma-associated interstitial lung disease: a systematic review.
Tiffany A Winstone, Deborah Assayag, Pearce G Wilcox, James V Dunne, Cameron J Hague, Jonathon Leipsic, Harold R Collard, Christopher J Ryerson. Chest 2014
115
21

Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease.
Joshua J Solomon, Jonathan H Chung, Gregory P Cosgrove, M Kristen Demoruelle, Evans R Fernandez-Perez, Aryeh Fischer, Stephen K Frankel, Stephen B Hobbs, Tristan J Huie, Jill Ketzer,[...]. Eur Respir J 2016
133
21

Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis from Other Idiopathic Interstitial Pneumonias.
Eric S White, Meng Xia, Susan Murray, Rachel Dyal, Candace M Flaherty, Kevin R Flaherty, Bethany B Moore, Ling Cheng, Tracy J Doyle, Julian Villalba,[...]. Am J Respir Crit Care Med 2016
80
21

Elevated MMP-7 levels in patients with systemic sclerosis: correlation with pulmonary involvement.
Pia Moinzadeh, Thomas Krieg, Martin Hellmich, Jürgen Brinckmann, Elena Neumann, Ulf Müller-Ladner, Alexander Kreuter, Daniel Dumitrescu, Stephan Rosenkranz, Nicolas Hunzelmann. Exp Dermatol 2011
36
21

Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients.
Katrin Schmidt, Lorena Martinez-Gamboa, Susan Meier, Christian Witt, Christian Meisel, Leif G Hanitsch, Mike O Becker, Doerte Huscher, Gerd R Burmester, Gabriela Riemekasten. Arthritis Res Ther 2009
72
21

Cellular interactions in the pathogenesis of interstitial lung diseases.
Gianluca Bagnato, Sergio Harari. Eur Respir Rev 2015
134
21

The impact of TGF-β on lung fibrosis: from targeting to biomarkers.
Isis E Fernandez, Oliver Eickelberg. Proc Am Thorac Soc 2012
338
21


Serum KL-6 and surfactant protein-D as monitoring and predictive markers of interstitial lung disease in patients with systemic sclerosis and mixed connective tissue disease.
Hideaki Yamakawa, Eri Hagiwara, Hideya Kitamura, Yumie Yamanaka, Satoshi Ikeda, Akimasa Sekine, Tomohisa Baba, Koji Okudela, Tae Iwasawa, Tamiko Takemura,[...]. J Thorac Dis 2017
19
26

Can serum surfactant protein D or CC-chemokine ligand 18 predict outcome of interstitial lung disease in patients with early systemic sclerosis?
Mona Elhaj, Julio Charles, Claudia Pedroza, Xiaochun Liu, Xiaodong Zhou, Rosa M Estrada-Y-Martin, Emilio B Gonzalez, Dorothy E Lewis, Hilda T Draeger, Sarah Kim,[...]. J Rheumatol 2013
40
21

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu, Martine Remy-Jardin, Jeffrey L Myers, Luca Richeldi, Christopher J Ryerson, David J Lederer, Juergen Behr, Vincent Cottin, Sonye K Danoff, Ferran Morell,[...]. Am J Respir Crit Care Med 2018
21

Does C-reactive protein predict the long-term progression of interstitial lung disease and survival in patients with early systemic sclerosis?
Xiaochun Liu, Maureen D Mayes, Claudia Pedroza, Hilda T Draeger, Emilio B Gonzalez, Brock E Harper, John D Reveille, Shervin Assassi. Arthritis Care Res (Hoboken) 2013
59
21

Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage.
Mirko Manetti, Serena Guiducci, Eloisa Romano, Silvia Bellando-Randone, Maria Letizia Conforti, Lidia Ibba-Manneschi, Marco Matucci-Cerinic. Ann Rheum Dis 2012
60
21

Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study.
R Gisli Jenkins, Juliet K Simpson, Gauri Saini, Jane H Bentley, Anne-Marie Russell, Rebecca Braybrooke, Philip L Molyneaux, Tricia M McKeever, Athol U Wells, Aiden Flynn,[...]. Lancet Respir Med 2015
169
17

TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis.
Justin M Oldham, Shwu-Fan Ma, Fernando J Martinez, Kevin J Anstrom, Ganesh Raghu, David A Schwartz, Eleanor Valenzi, Leah Witt, Cathryn Lee, Rekha Vij,[...]. Am J Respir Crit Care Med 2015
156
17

Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.
Imre Noth, Yingze Zhang, Shwu-Fan Ma, Carlos Flores, Mathew Barber, Yong Huang, Steven M Broderick, Michael S Wade, Pirro Hysi, Joseph Scuirba,[...]. Lancet Respir Med 2013
304
17

Predicting survival across chronic interstitial lung disease: the ILD-GAP model.
Christopher J Ryerson, Eric Vittinghoff, Brett Ley, Joyce S Lee, Joshua J Mooney, Kirk D Jones, Brett M Elicker, Paul J Wolters, Laura L Koth, Talmadge E King,[...]. Chest 2014
205
17

Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis.
Tasha E Fingerlin, Elissa Murphy, Weiming Zhang, Anna L Peljto, Kevin K Brown, Mark P Steele, James E Loyd, Gregory P Cosgrove, David Lynch, Steve Groshong,[...]. Nat Genet 2013
414
17

A multidimensional index and staging system for idiopathic pulmonary fibrosis.
Brett Ley, Christopher J Ryerson, Eric Vittinghoff, Jay H Ryu, Sara Tomassetti, Joyce S Lee, Venerino Poletti, Matteo Buccioli, Brett M Elicker, Kirk D Jones,[...]. Ann Intern Med 2012
582
17

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Ganesh Raghu, Kevin J Anstrom, Talmadge E King, Joseph A Lasky, Fernando J Martinez. N Engl J Med 2012
854
17



Characterisation of patients with interstitial pneumonia with autoimmune features.
Justin M Oldham, Ayodeji Adegunsoye, Eleanor Valenzi, Cathryn Lee, Leah Witt, Lena Chen, Aliya N Husain, Steven Montner, Jonathan H Chung, Vincent Cottin,[...]. Eur Respir J 2016
131
17

An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.
William D Travis, Ulrich Costabel, David M Hansell, Talmadge E King, David A Lynch, Andrew G Nicholson, Christopher J Ryerson, Jay H Ryu, Moisés Selman, Athol U Wells,[...]. Am J Respir Crit Care Med 2013
17

Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis.
H Takahashi, Y Kuroki, H Tanaka, T Saito, K Kurokawa, H Chiba, A Sagawa, H Nagae, S Abe. Am J Respir Crit Care Med 2000
105
17

An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial.
Dinesh Khanna, Carlo Albera, Aryeh Fischer, Nader Khalidi, Ganesh Raghu, Lorinda Chung, Dan Chen, Elena Schiopu, Margit Tagliaferri, James R Seibold,[...]. J Rheumatol 2016
121
17

Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids.
Y Honda, Y Kuroki, E Matsuura, H Nagae, H Takahashi, T Akino, S Abe. Am J Respir Crit Care Med 1995
226
17

Chronic hypersensitivity pneumonitis: high resolution computed tomography patterns and pulmonary function indices as prognostic determinants.
Simon L F Walsh, Nicola Sverzellati, Anand Devaraj, Athol U Wells, David M Hansell. Eur Radiol 2012
104
17


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.